The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease

Tissue Antigens

Volumn 66, Issue 4, 2005, Pages 314-317

  Martin Ma C ^a   Oliver, J ^b   Urcelay, E ^a   Orozco, G ^b   Gomez Garcia M ^c   Lopez Nevot M A ^c   Pinero A ^d   Brieva, J A ^d   De La Concha, E G ^a   Nieto, A ^d   Martin, Javier ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Crohn's disease; Inflammatory bowel disease; Lymphoid specific phosphatase (LYP); PTPN22; Ulcerative colitis

Indexed keywords

CYTOSINE; LYMPHOID SPECIFIC PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR 22; TAQ POLYMERASE; THYMINE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PTPN22 GENE; REAL TIME POLYMERASE CHAIN REACTION; SPAIN; ULCERATIVE COLITIS;

ALLELES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE; SPAIN;

EID: 26044482775     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00428.x     Document Type: Article

References (30)

1. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988: 29: 990-6.
2. Monsen U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol 1991: 26: 302-6.
3. Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum Mol Genet 2004: 13 Spec No 1: R161-8.
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003: 3: 521-33.
5. Alonso A, Sasin J, Bottini N et al. Protein tyrosine phosphatases in the human genome. Cell 2004: 117: 699-711.
6. Mustelin T, Alonso A, Bottini N et al. Protein tyrosine phosphatases in T cell physiology. Mol Immunol 2004: 41: 687-700.
7. Andersen JN, Jansen PG, Echwald SM et al. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. Faseb J 2004: 18: 8-30.
8. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999: 93: 2013-24.
9. Cloutier JF, Veillette A. Association of inhibitory tyrosine protein kinase pSOcsk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. Embo J 1996: 15: 4909-18.
10. Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 1999: 189: 111-21.
11. Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004: 36: 337-8.
12. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004: 75: 330-7.
13. Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004: 75: 504-7.
14. Begovich AB, Caillier SJ, Alexander HC et al. The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis. Am J Hum Genet 2005: 76: 184-7.
15. Matesanz F, Rueda B, Orozco G et al. Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis. J Neurol. 17: 2005: [Epub ahead of print]
16. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989: 170: 2-6.
17. Orozco G, Sanchez E, Gonzalez-Gay MA et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005: 52: 219-24.
18. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002: 155: 478-84.
19. Viken MK, Amundsen SS, Kvien TK et al. Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun. (Epub ahead of print)
20. Velaga MR, Wilson V, Jennings CE et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 2004: 89: 5862-5.
21. Smyth D, Cooper JD, Collins JE et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004: 53: 3020-3.
22. Criswell LA, Pfeiffer KA, Lum RF et al. Analysis of Families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005: 76: 561-71. (Epub 2005 February 17)
23. Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 2004: 4: 167-74.
24. Furugaki K, Shirasawa S, Ishikawa N et al. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet 2004: 49: 166-8.
25. Torres B, Aguilar F, Franco E et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 2004: 5: 2211-5.
26. Orozco G, Torres B, Nunez-Roldan A, Gonzalez-Escribano MF, Martin J. Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis. Tissue Antigens 2004: 64: 667-70.
27. Barton A, Jury F, Eyre S et al. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum 2004: 50: 748-52.
28. King AL, Moodie SJ, Fraser JS et al. Coeliac disease: investigation of proposed causal variants in the CTLA4 gene region. Eur J Immunogenet 2003: 30: 427-32.
29. Amundsen SS, Naluai AT, Ascher H et al. Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 2004: 64: 593-9.
30. Rueda B, Zhernakova AMA, López-Nevot M et al. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders. Hum Immunol. 2005: 66: 321-5.